Published in J Hypertens on February 01, 2017
Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol (2005) 2.43
Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood (2003) 2.28
Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens (2005) 2.04
Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem (2002) 1.90
Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem (2006) 1.73
Role of oxidative stress in erythropoietin-induced hypertension in uremic rats. Am J Hypertens (2009) 1.44
Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell (2007) 1.41
Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF. J Biol Chem (2005) 1.38
Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int (2004) 1.30
Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell (2010) 1.25
Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem (2004) 1.17
Intermittent PTH(1-84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites. J Bone Miner Res (2011) 1.10
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis (2009) 1.09
Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension (2007) 1.08
Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Mol Cell Biol (2011) 1.03
Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol (2007) 1.02
Impact of age on glomerular filtration estimates. Nephrol Dial Transplant (2008) 1.01
Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells. Endocrinology (2007) 1.01
HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism. Cardiovasc Res (2010) 0.95
Specific role of dopamine D1 receptors in spinal network activation and rhythmic movement induction in vertebrates. J Physiol (2009) 0.95
Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension (2013) 0.94
RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol (2011) 0.93
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest (2005) 0.92
Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol (2012) 0.91
Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Am J Kidney Dis (2005) 0.90
TGFbeta-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration. Cell Signal (2009) 0.89
Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. Arterioscler Thromb Vasc Biol (2009) 0.88
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol (2009) 0.87
Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens (2013) 0.86
Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant (2011) 0.84
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases. Am J Physiol Heart Circ Physiol (2010) 0.83
Age-related and blood pressure-independent reduction in aortic stiffness after kidney transplantation. J Hypertens (2011) 0.83
eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. Nephrol Dial Transplant (2011) 0.82
Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy. Biotechnol J (2010) 0.81
Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantation. Nephrol Dial Transplant (2007) 0.81
The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease. Nephrol Dial Transplant (2009) 0.81
Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant (2009) 0.80
Dual-kidney transplants as an alternative for very marginal donors: long-term follow-up in 63 patients. Transplantation (2010) 0.80
Plasticity in sublesionally located neurons following spinal cord injury. J Neurophysiol (2007) 0.79
Strain-dependent recovery of spontaneous hindlimb movement in spinal cord transected mice (CD1, C57BL/6, BALB/c). Behav Neurosci (2006) 0.79
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors. Mol Pharmacol (2008) 0.79
The Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity. Exp Cell Res (2012) 0.78
Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy. Transplantation (2015) 0.78
Arterial stiffness and dialysis calcium concentration. Int J Nephrol (2011) 0.78
Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice. J Pharmacol Exp Ther (2008) 0.78
Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1. Mol Biol Cell (2014) 0.78
Effects on locomotion, muscle, bone, and blood induced by a combination therapy eliciting weight-bearing stepping in nonassisted spinal cord-transected mice. Neurorehabil Neural Repair (2010) 0.78
Tail pinching-induced hindlimb movements are suppressed by clonidine in spinal cord injured mice. Behav Neurosci (2008) 0.77
Impact of donor age on long-term outcomes after delayed graft function: 10-year follow-up. Transpl Int (2012) 0.77
Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis. Int Urol Nephrol (2013) 0.77
Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake. Clin Exp Hypertens (2007) 0.77
Impact of an obesogenic diet program on bone densitometry, micro architecture and metabolism in male rat. Lipids Health Dis (2012) 0.77
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am J Hypertens (2006) 0.77
Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation (2004) 0.77
Hormonal and immunological changes in mice after spinal cord injury. J Neurotrauma (2007) 0.76
[HIF-1 activation during tumor progression: implications and consequences]. Bull Cancer (2006) 0.75
Green dialysate: asymptomatic perforated cholecystitis without peritonitis. Nephrol Dial Transplant (2006) 0.75
Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study. Medicine (Baltimore) (2017) 0.75
Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. Clin Nucl Med (2015) 0.75
Uric acid association with pulsatile and steady components of central and peripheral blood pressures. J Hypertens (2017) 0.75
Effects of TGF-beta1 on endothelial factors. Arch Physiol Biochem (2010) 0.75
In vivo quantification of central venous catheter leak. Nephrol Dial Transplant (2005) 0.75
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis. J Hypertens (2016) 0.75
Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant (2004) 0.75